Congestive Heart Failure: Pharmacological Agents and the Potential of BType Natriuretic Peptide

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|12|12|1439-1447

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.12, Iss.12, 2005-06, pp. : 1439-1447

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Albubnp, a Recombinant B-type Natriuretic Peptide and Human Serum Albumin Fusion Hormone, as a Long-Term Therapy of Congestive Heart Failure

By Wang Wei   Ou Ying   Shi Yanggu  

Pharmaceutical Research, Vol. 21, Iss. 11, 2004-11 ,pp. : 2105-2111

Springer Publishing Company

Access to resources Recommend Favorite

Recent advances in natriuretic peptides in congestive heart failure

By Boerrigter Guido   Burnett Jr John C  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 6, 2004-06 ,pp. : 643-652

Informa Healthcare

Access to resources Recommend Favorite

Biological Actions and Metabolism of Currently Used Pharmacological Agents for the Treatment of Congestive Heart Failure

By  

Current Drug Metabolism, Vol. 10, Iss. 3, 2009-03 ,pp. : 206-219

Bentham Science Publishers

Access to resources Recommend Favorite

Natriuretic Peptide Guided Heart Failure Management

By  

Current Clinical Pharmacology, Vol. 4, Iss. 2, 2009-05 ,pp. : 87-94

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Anticytokine Therapy in Congestive Heart Failure

By Aukrust P.   Yndestad A.  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 3, 2004-01 ,pp. : 169-177

Adis International

Access to resources Recommend Favorite